01.08.2018
- The US Food and Drug Administration has accepted the resubmission of Merck KGaA’s New Drug Application (NDA) for cladribine tablets as a potential treatment for patients with...
16.11.2017
- French drugmaker Sanofi has signed an agreement to develop Principia Biopharma’s experimental oral treatment that is seen to show promise in treating multiple sclerosis (MS) and...
